| Financial Year |
March 31 2023 |
| Monetary Funds |
478,560,387.19 |
| Held-for-trading Financial Assets |
21,553.00 |
| Notes Receivable |
3,347,571.20 |
| Accounts Receivable |
5,851,828,150.64 |
| Advances to Suppliers |
391,556,765.43 |
| Other Receivables |
94,964,775.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,384,082,334.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
66,615,130.09 |
| Total Current Assets |
9,289,878,740.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
34,706,801.07 |
| Investment Properties |
24,483,775.37 |
| Fixed Assetes |
809,537,812.95 |
| Under-construction Projects |
525,437,334.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
175,946,078.86 |
| R&D expenses |
-- |
| Goodwill |
288,651,455.27 |
| Long-Term Deferred and Prepaid Expenses |
29,240,921.86 |
| Deferred Income Tax Assets |
60,880,089.00 |
| Other Non-Current Assets |
3,686,409.78 |
| Sub-Total of Non-Current Assets |
2,059,962,452.65 |
| Total Assets |
11,349,841,193.41 |
| Short-Term Loans |
4,467,684,054.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
841,696,664.51 |
| Accounts Payable |
1,908,847,460.33 |
| Accounts Received In Advance |
40,592.50 |
| Employee Compensation Payable |
41,372,464.63 |
| Taxes Payable |
73,513,768.62 |
| Interest Payable |
-- |
| Dividend Payable |
665,008.65 |
| Other payables |
246,654,173.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
77,380,018.12 |
| Other Current Liabilities |
3,981,016.34 |
| Sub-Total of Current Liabilities |
7,693,577,607.52 |
| Long-term Loans |
568,506,325.58 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
110,892,438.23 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,982,835.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
795,145,499.46 |
| Total Liabilities |
8,488,723,106.98 |
| Paid-In Capital(Or Share Stock) |
388,516,736.00 |
| Capital Surplus |
654,982,859.58 |
| Surplus Reserve |
184,609,253.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,571,128,161.03 |
| Minority Stockholder's Interest |
59,497,979.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,801,620,106.65 |
| Owner's Equity（Stockholder's Equity） |
2,861,118,086.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,349,841,193.41 |
